Previous Article | Next Article ![]()
Applied and Environmental Microbiology, July 2001, p. 3110-3114, Vol. 67, No. 7
U.S. Food and Drug Administration, Pacific
Regional Laboratory-Northwest, Bothell, Washington
98021-4421,1 and Division of
Microbiological Studies, U.S. Food and Drug Administration, Washington,
D.C. 202042
Received 25 January 2001/Accepted 25 April 2001
The enzyme glutamate decarboxylase (GAD) is prevalent in
Escherichia coli but few strains in the various pathogenic
E. coli groups have been tested for GAD. Using PCR primers
that amplify a 670-bp segment from the gadA and
gadB genes encoding GAD, we examined the distribution of
the gadAB genes among enteric bacteria. Analysis of 173 pathogenic E. coli strains, including 125 enterohemorrhagic E. coli isolates of the O157:H7 serotype and its phenotypic
variants and 48 isolates of enteropathogenic E. coli,
enterotoxigenic E. coli, enteroinvasive E. coli, and other Shiga toxin-producing E. coli (STEC)
serotypes, showed that gadAB genes were present in all
these strains. Among the 22 non-E. coli isolates tested, only the 6 Shigella spp. carried gadAB.
Analysis of naturally contaminated water and food samples using a
gadAB-specific DNA probe that was labeled with digoxigenin
showed that a gadAB-based assay is as reliable as standard
methods that enumerate E. coli organisms on the basis of
lactose fermentation. The presence of few E. coli cells
initially seeded into produce rinsates could be detected by PCR to
gadA/B genes after overnight enrichment. A multiplex PCR
assay using the gadAB primers in combination with primers
to Shiga toxin (Stx) genes stx1 and
stx2 was effective in detecting STEC from the
enrichment medium after seeding produce rinsate samples with as few as
2 CFU. The gadAB primers may be multiplexed with primers to
other trait virulence markers to specifically identify other pathogenic
E. coli groups.
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.7.3110-3114.2001
Glutamate Decarboxylase Genes as a Prescreening
Marker for Detection of Pathogenic Escherichia coli
Groups
*
Corresponding author. Mailing address: U.S. Food and
Drug Administration, 22201 23rd Dr. SE, Bothell, WA 98021-4421. Phone: (425) 486-8788. Fax: (425) 483-4996. E-mail:
mgrant{at}ora.fda.gov.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»